Apps Purchases: 10+ Million Software Purchases
Founded in 2010, APPS RUN THE WORLD is a leading technology intelligence and market-research company devoted to the application space. Leveraging a rigorous data-centric research methodology, we ask the simple B2B sales intelligence question: Who’s buying enterprise applications from whom and why?
Our global team of 50 researchers has been studying the digital transformation initiatives being undertaken by 2 million + companies including technographic segmentation of 10 million ERP, EPM, CRM, HCM, Procurement, SCM, Treasury software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Apps Run The World Buyer Insight and Technographics Customer Database has over 100 data fields that detail company usage of emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database, and different on-prem and cloud apps by function, customer size (employees, revenues), industry, country, implementation status, year deal won, partner involvement, Line of Business Key Stakeholders and key decision-makers contact details, including the systems being used by Fortune 1000 and Global 2000 companies.
Apply Filters For 10+ Million Software Purchases
- Analytics and BI
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | VAR/SI | Insight | Insight Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Japan Medical Supply | Life Sciences | 5359 | $505M | Japan | Ultimus | Ultimus Digital Process Automation Suite | Process Mining | 2018 | n/a | In 2018 Japan Medical Supply implemented Ultimus Digital Process Automation Suite to introduce Process Mining capabilities across its Japan operations. Japan Medical Supply used the Ultimus Digital Process Automation Suite as a Process Mining platform to analyze order to cash and procurement business functions and to provide visibility into end to end transactional workflows. The deployment emphasized enterprise process discovery and performance monitoring to surface variation and compliance gaps across core operational flows. Configuration and module selection centered on event log ingestion, process model visualization, conformance checking, and workflow orchestration features available within the Ultimus Digital Process Automation Suite. Governance was adapted toward centralized process analytics with role based access controls and process owner workflows to operationalize insights and manage remediation. Rollout was staged by workflow complexity and operational criticality, embedding process governance into existing operational management structures. | |
|
|
TherapeuticsMD | Life Sciences | 400 | $64M | United States | Definitive Healthcare | Definitive Healthcare HospitalView | Analytics and BI | 2016 | n/a | In 2016, TherapeuticsMD implemented Definitive Healthcare HospitalView as part of its Analytics and BI tooling to support hospital and provider intelligence. Definitive Healthcare HospitalView was adopted to provide hospital-level analytics and to centralize facility and service line data for commercial decision making. The deployment focused on analytic content and dashboards typical of Analytics and BI platforms, including hospital profiles, service line and procedure volume reporting, market share and competitive set visualizations, and account-level intelligence for territory planning. Configuration emphasized curated datasets, role-based dashboards, and scheduled data refresh workflows consistent with hospital analytics use cases. Operational adoption centered on commercial functions, including sales operations, market access, and medical affairs, where hospital and provider insights inform targeting and engagement strategies. Access was provisioned through role-based controls and analyst-facing dashboards, while data stewardship responsibilities were assigned to centralized analytics owners to maintain data quality and taxonomy. Governance incorporated phased rollout and user enablement, with formalized training and documentation to support adoption across teams. Controls around user access and dashboard publishing were established to ensure consistent reporting and to align HospitalView outputs with TherapeuticsMD business workflows. | |
|
|
|
Life Sciences | 2227 | $682M | United States | Oracle | Oracle OBIA | Analytics and BI | 2016 | n/a |
|
|
|
|
|
Life Sciences | 1000 | $250M | United States | Oracle | Oracle OBIA | Analytics and BI | 2014 | n/a |
|
|
|
|
|
Life Sciences | 1000 | $250M | United States | Oracle | Oracle OBIEE | Analytics and BI | 2014 | n/a |
|
|
|
|
|
Life Sciences | 7063 | $4.0B | United States | Oracle | Oracle OBIA | Analytics and BI | 2013 | n/a |
|
|
|
|
|
Life Sciences | 7063 | $4.0B | United States | Oracle | Oracle OBIEE | Analytics and BI | 2013 | n/a |
|
|
|
|
|
Life Sciences | 650 | $150M | United States | Oracle | Oracle OBIA | Analytics and BI | 2013 | n/a |
|
|
|
|
|
Life Sciences | 650 | $150M | United States | Oracle | Oracle OBIEE | Analytics and BI | 2013 | n/a |
|
|
|
|
|
Life Sciences | 18000 | $6.5B | United States | Oracle | Oracle Endeca | Analytics and BI | 2015 | n/a |
|
|